结合ATP的磁带输送器缺陷及其在肝脏疾病中的作用
1Department of Medicine, University of Connecticut Health Center, Farmington, CT, USA.
Journal of clinical and translational hepatology
|February 9, 2026
概括
在ATP结合盒 (ABC) 载体中发生的突变会导致各种肝脏疾病,从轻度到重度. 基因检测有助于对这些胆固醇性肝病的诊断和预后.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- ATP结合盒 (ABC) 载体对于将分子运送到胆管中至关重要.
- 如BSEP,MDR3,ABCG5/8和MRP2等ABC载体的缺陷导致了一系列的肝病.
- 疾病的严重程度是由遗传因素 (zygosity,突变类型) 和环境影响所调节的.
研究的目的:
- 审查与ABC载体突变相关的肝病.
- 讨论影响疾病严重程度的遗传和环境因素.
- 涵盖这些胆固醇状况的临床表现,诊断和治疗策略.
主要方法:
- 关于与ABC载体突变相关的肝病的文献综述.
- 对影响疾病严重程度的遗传和环境因素的分析.
- 讨论诊断方法和治疗选择.
主要成果:
- 特定的ABC载体基因突变 (ABCB11,ABCB4,ABCG5/8,ABCC2) 与各种肝脏病理有关.
- 同卵性/复合异卵性突变通常会导致严重的,早期发病的疾病,而异卵性突变会导致较轻的形式.
- 下一代基因测试提供了高的诊断和预后价值.
结论:
- 了解特定的ABC转运器突变是准确诊断和预后的关键.
- 遗传和环境因素显著影响这些肝病的临床谱.
- 向疗法对治疗由ABC输送器缺陷引起的严重胆固醇性肝病具有前途.
相关概念视频
Hepatic Drug Clearance: Role of Transporters
311
In the liver and bile canaliculi, influx and efflux transporters modification can influence intrinsic clearance. Transporters play a significant role in moving drugs within liver cells. Elaborate models, such as the Biopharmaceutical Classification System (BCS), are essential to relate transporters to drug disposition. This system categorizes drugs into four classes based on solubility and permeability, providing insights into elimination routes and the effects of transporters following oral...
311
ATP Yield
79.1K
Cellular respiration produces 30 - 32 ATP per glucose molecule. Although most of the ATP results from oxidative phosphorylation and the electron transport chain (ETC), 4 ATP are gained beforehand (2 from glycolysis and 2 from the citric acid cycle).
The ETC is embedded in the inner mitochondrial membrane and is comprised of four main protein complexes and an ATP synthase. NADH and FADH2 pass electrons to these complexes, which pump protons into the intermembrane space. This distribution of...
The ETC is embedded in the inner mitochondrial membrane and is comprised of four main protein complexes and an ATP synthase. NADH and FADH2 pass electrons to these complexes, which pump protons into the intermembrane space. This distribution of...
79.1K
Nonlinear Pharmacokinetics: Role of Transporters
298
A drug's nonlinear kinetics can be influenced by a diverse range of transporter proteins that serve as crucial players in drug distribution. These transporters, found within cells, can enhance or reduce local drug concentrations by facilitating the influx or efflux of drugs. For instance, the expression of xenobiotic transporters can be influenced by factors such as age and gender, potentially impacting the linearity of drug response.
Polymorphisms occurring in drug transporters can alter...
Polymorphisms occurring in drug transporters can alter...
298
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
281
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
281
Hepatic Drug Clearance: Effect of Protein Binding
565
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
565
Primary Active Transport
199.9K
In contrast to passive transport, active transport involves a substance being moved through membranes in a direction against its concentration or electrochemical gradient. There are two types of active transport: primary active transport and secondary active transport. Primary active transport utilizes chemical energy from ATP to drive protein pumps that are embedded in the cell membrane. With energy from ATP, the pumps transport ions against their electrochemical gradients—a direction...
199.9K


